CO6321131A2 - N-hidroxiamidas omega- sustituidas con grupos triciclicos como inhibidores de histona desacetilasa su preparacion y uso en formulaciones farmaceuticas - Google Patents
N-hidroxiamidas omega- sustituidas con grupos triciclicos como inhibidores de histona desacetilasa su preparacion y uso en formulaciones farmaceuticasInfo
- Publication number
- CO6321131A2 CO6321131A2 CO07107398A CO07107398A CO6321131A2 CO 6321131 A2 CO6321131 A2 CO 6321131A2 CO 07107398 A CO07107398 A CO 07107398A CO 07107398 A CO07107398 A CO 07107398A CO 6321131 A2 CO6321131 A2 CO 6321131A2
- Authority
- CO
- Colombia
- Prior art keywords
- omega
- hydroxiamides
- deacetilate
- tricycles
- replaced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/36—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen nuevas N-hidroxiamidas de ácidos n-alquil carboxílicos omega sustituidos con oportuno sistema tricíclico caracterizado por un anillo central de sietemiembros que tienen la actividad como inhibidores de la histona desacetilasa (HDAC).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000042 IT1362675B (it) | 2005-03-15 | 2005-03-15 | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6321131A2 true CO6321131A2 (es) | 2011-09-20 |
Family
ID=36676439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO07107398A CO6321131A2 (es) | 2005-03-15 | 2007-10-12 | N-hidroxiamidas omega- sustituidas con grupos triciclicos como inhibidores de histona desacetilasa su preparacion y uso en formulaciones farmaceuticas |
Country Status (22)
Country | Link |
---|---|
US (1) | US20080275023A1 (es) |
EP (1) | EP1863776A1 (es) |
JP (1) | JP2008533088A (es) |
KR (1) | KR20080003336A (es) |
CN (1) | CN101142197A (es) |
AP (1) | AP2007004170A0 (es) |
AR (1) | AR053171A1 (es) |
AU (1) | AU2006222883A1 (es) |
BR (1) | BRPI0608549A2 (es) |
CA (1) | CA2600521A1 (es) |
CO (1) | CO6321131A2 (es) |
EA (1) | EA013015B1 (es) |
IL (1) | IL185879A0 (es) |
IT (1) | IT1362675B (es) |
MA (1) | MA29673B1 (es) |
MX (1) | MX2007011071A (es) |
NI (1) | NI200700222A (es) |
NO (1) | NO20075229L (es) |
SA (1) | SA06270133B1 (es) |
TW (1) | TW200719900A (es) |
WO (1) | WO2006097449A1 (es) |
ZA (1) | ZA200708754B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0523040D0 (en) * | 2005-11-11 | 2005-12-21 | Cyclacel Ltd | Combination |
CN103275067B (zh) * | 2006-10-28 | 2015-09-02 | 梅特希尔基因公司 | 组蛋白脱乙酰酶抑制剂 |
AU2013205135B2 (en) * | 2006-10-28 | 2015-11-05 | Forum Pharmaceuticals Inc. | Inhibitors of histone deacetylase |
EP2102201B1 (en) * | 2006-12-11 | 2010-10-13 | Merck Sharp & Dohme Corp. | Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators |
JP2011102240A (ja) * | 2008-02-29 | 2011-05-26 | Univ Of Tokyo | 三環性化合物 |
US8202989B2 (en) | 2009-01-12 | 2012-06-19 | Council Of Scientific And Industrial Research | One step process for the preparation of substituted 5, 10-dihydrodibenzo [b,e][1, 4]diazepine-11-ones |
CA2795952A1 (en) * | 2010-04-16 | 2011-10-20 | Curis, Inc. | Treatment of cancers having k-ras mutations |
WO2012045194A1 (en) * | 2010-10-09 | 2012-04-12 | Abbott Laboratories | Benzodiazepinones as fak inhibitors for treatment of cancer |
RU2519546C1 (ru) * | 2013-01-16 | 2014-06-10 | Общество С Ограниченной Ответственностью "Биоинтегратор" (Ооо "Биоинтегратор") | КОНЪЮГАТЫ И МАЛЫЕ МОЛЕКУЛЫ, ВЗАИМОДЕЙСТВУЮЩИЕ С РЕЦЕПТОРОМ CD16а |
JP2016508521A (ja) | 2013-02-19 | 2016-03-22 | アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai | 抗腫瘍剤としての三環式複素環 |
CN106458936A (zh) | 2014-03-11 | 2017-02-22 | 西奈山伊坎医学院 | 作为抗癌药的三环‑2‑氨基环烷醇衍生的磺酰胺 |
EP3116857B1 (en) | 2014-03-11 | 2019-02-06 | Icahn School of Medicine at Mount Sinai | Constrained tricyclic sulfonamides |
WO2016083276A1 (de) | 2014-11-25 | 2016-06-02 | Bayer Pharma Aktiengesellschaft | Substituierte pyridobenzodiazepinon-derivate und ihre verwendung |
US10086000B2 (en) | 2014-12-05 | 2018-10-02 | Merck Sharp & Dohme Corp. | Tricyclic compounds as inhibitors of mutant IDH enzymes |
EP3226689B1 (en) | 2014-12-05 | 2020-01-15 | Merck Sharp & Dohme Corp. | Novel tricyclic compounds as inhibitors of mutant idh enzymes |
US10442819B2 (en) | 2014-12-05 | 2019-10-15 | Merck Sharp & Dohme Corp. | Tricyclic compounds as inhibitors of mutant IDH enzymes |
GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
CA2997769A1 (en) | 2015-09-09 | 2017-03-16 | Icahn School Of Medicine At Mount Sinai | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents |
WO2017044571A1 (en) * | 2015-09-09 | 2017-03-16 | Icahn School Of Medicine At Mount Sinai | Tricyclic sultam sulfonamides as anticancer and neuroprotective agents |
JP6955485B2 (ja) | 2015-09-09 | 2021-10-27 | アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai | 抗がん剤としての複素環式の限定された三環系スルホンアミド |
CN105806973B (zh) * | 2016-03-10 | 2019-01-18 | 中国医学科学院肿瘤医院 | Uplc-ms/ms法测定人血浆中莎巴比星及其代谢产物m3的血药浓度 |
WO2019157020A1 (en) | 2018-02-06 | 2019-08-15 | The Board Of Trustees Of The University Of Illinois | Substituted benzothiophene analogs as selective estrogen receptor degraders |
KR102301274B1 (ko) * | 2019-08-05 | 2021-09-14 | 리퓨어생명과학 주식회사 | 히스톤 아세틸트렌스퍼라제 p300 억제용 신규 화합물 및 이를 포함하는 항섬유화 조성물 |
KR102243465B1 (ko) * | 2019-08-05 | 2021-04-22 | 리퓨어생명과학 주식회사 | 히스톤 아세틸트렌스퍼라제 p300 억제용 신규 화합물 및 이를 포함하는 항섬유화 조성물 |
WO2023020416A1 (zh) * | 2021-08-16 | 2023-02-23 | 勤浩医药(苏州)有限公司 | 三环化合物、包含其的药物组合物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6033110B2 (ja) * | 1977-09-12 | 1985-08-01 | 帝国臓器製薬株式会社 | ジベンズアゼピン誘導体 |
JPS53121780A (en) * | 1977-04-01 | 1978-10-24 | Teikoku Hormone Mfg Co Ltd | Dibenzazepin derivatives and process for their preparation |
AR035455A1 (es) * | 2001-04-23 | 2004-05-26 | Hoffmann La Roche | Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos |
KR20050110612A (ko) * | 2002-12-25 | 2005-11-23 | 다이이찌 세이야꾸 가부시기가이샤 | 디아민 유도체 |
-
2005
- 2005-03-15 IT IT000042 patent/IT1362675B/it active
-
2006
- 2006-03-07 TW TW095107553A patent/TW200719900A/zh unknown
- 2006-03-13 BR BRPI0608549-0A patent/BRPI0608549A2/pt not_active IP Right Cessation
- 2006-03-13 US US11/886,168 patent/US20080275023A1/en not_active Abandoned
- 2006-03-13 CN CNA2006800082490A patent/CN101142197A/zh active Pending
- 2006-03-13 WO PCT/EP2006/060661 patent/WO2006097449A1/en active Application Filing
- 2006-03-13 AU AU2006222883A patent/AU2006222883A1/en not_active Abandoned
- 2006-03-13 CA CA002600521A patent/CA2600521A1/en not_active Abandoned
- 2006-03-13 MX MX2007011071A patent/MX2007011071A/es not_active Application Discontinuation
- 2006-03-13 KR KR1020077023278A patent/KR20080003336A/ko not_active Application Discontinuation
- 2006-03-13 EP EP06708743A patent/EP1863776A1/en not_active Withdrawn
- 2006-03-13 AP AP2007004170A patent/AP2007004170A0/xx unknown
- 2006-03-13 EA EA200701969A patent/EA013015B1/ru unknown
- 2006-03-13 JP JP2008501283A patent/JP2008533088A/ja active Pending
- 2006-03-14 AR ARP060100976A patent/AR053171A1/es not_active Application Discontinuation
- 2006-05-08 SA SA06270133A patent/SA06270133B1/ar unknown
-
2007
- 2007-08-23 NI NI200700222A patent/NI200700222A/es unknown
- 2007-09-10 IL IL185879A patent/IL185879A0/en unknown
- 2007-10-11 MA MA30292A patent/MA29673B1/fr unknown
- 2007-10-12 NO NO20075229A patent/NO20075229L/no not_active Application Discontinuation
- 2007-10-12 CO CO07107398A patent/CO6321131A2/es not_active Application Discontinuation
- 2007-10-12 ZA ZA200708754A patent/ZA200708754B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
TW200719900A (en) | 2007-06-01 |
AU2006222883A1 (en) | 2006-09-21 |
MA29673B1 (fr) | 2008-08-01 |
AR053171A1 (es) | 2007-04-25 |
KR20080003336A (ko) | 2008-01-07 |
NO20075229L (no) | 2007-11-08 |
EA013015B1 (ru) | 2010-02-26 |
EP1863776A1 (en) | 2007-12-12 |
WO2006097449A1 (en) | 2006-09-21 |
JP2008533088A (ja) | 2008-08-21 |
CA2600521A1 (en) | 2006-09-21 |
IT1362675B (it) | 2009-06-25 |
ZA200708754B (en) | 2008-10-29 |
MX2007011071A (es) | 2007-10-08 |
AP2007004170A0 (en) | 2007-10-31 |
ITFI20050042A1 (it) | 2006-09-16 |
NI200700222A (es) | 2008-07-24 |
CN101142197A (zh) | 2008-03-12 |
EA200701969A1 (ru) | 2008-02-28 |
SA06270133B1 (ar) | 2009-05-16 |
IL185879A0 (en) | 2008-01-06 |
BRPI0608549A2 (pt) | 2010-01-12 |
US20080275023A1 (en) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6321131A2 (es) | N-hidroxiamidas omega- sustituidas con grupos triciclicos como inhibidores de histona desacetilasa su preparacion y uso en formulaciones farmaceuticas | |
CR9430A (es) | N-hidroxiamidas omega-sustituidas con grupos triciclos como inhibidores de histona desacetilasa, su preparacion y uso en formulaciones farmaceuticas | |
NO20043612L (no) | Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler | |
UY28673A1 (es) | Planta de maiz mon88017 y composiciones y metodos de deteccion de la misma | |
ECSP088800A (es) | Formulaciones de inhibidores de DPP IV | |
ECSP10010489A (es) | Nuevas formulaciones, comprimidos que comprenden tales formulaciones, su uso y procedimiento para su preparación | |
BR112015023434A8 (pt) | compostos inibidores de histona deacetilase, seu uso e composição farmacêutica que os compreende | |
CL2007003303A1 (es) | Molecula de enlace para la proteina lingo-1; polinucleotido que la codifica; vector y celula que lo comprenden; composicion farmaceutica que comprende la molecula de enlace; y su uso para el tratamiento de lesiones del sistema nervioso central. | |
CL2009000447A1 (es) | Compuestos derivados de (1h-pirrolo{2,3-b}piridin-5-il)-sulfonamido-benzamida sustituida; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento del cancer, a travez de la inhibicion de raf. | |
CL2008001274A1 (es) | Compuestos macrolidos derivados de 5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahidrociclopropan[e]pirrolo[1,2-a][1,4]diazaciclopentadecinilo, inhibidores de la actividad de la proteasa ns3-ns4; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios y procedimiento de preparacion; y uso en el tratamiento de..... | |
CR20110599A (es) | Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos | |
ECSP13012467A (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
NI200900071A (es) | Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a. | |
CL2008003576A1 (es) | Compuestos derivados de amida del acido 6,7-dihidro-5h-imidazo[1,2-alfa]imidazol-3-carboxilico; composicion farmaceutica que los comprende; y usos en el tratamiento de una afeccion inflamatoria. | |
CL2012001451A1 (es) | Composición farmacéutica en microcápsulas co-granuladas que comprenden fexofenadina y un revestimiento polímero insoluble en agua, de liberación inmediata y sabor enmascarado; procedimiento para su preparación; y su uso en condiciones inflamatorias como rinitis alérgica estacional o urticaria idiopática crónica | |
CO6640305A2 (es) | Elaboración de gránulos sin activos y tabletas que comprenden los mismos | |
UA99645C2 (ru) | Гель, имеющий противовоспалительное и противоаллергическое действие | |
GT201200304A (es) | Composiciones farmacéuticas que comprenden hidromorfona y naloxona | |
CL2011002522A1 (es) | Compuestos derivados de (piran-) o (tiopiran-)quinazolinadiona, inhibidores de fosfodiesterasa 7 (pde7); procedimiento de preparacion; composicicion farmaceutica; y uso para tratar una enfermedad inflamatoria, inmunoinflamatoria, cardiovascular, del sistema nervioso central y/o periferico. | |
CR10052A (es) | Proceso para la preparación de aminas | |
TW200724529A (en) | Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them | |
CL2008001810A1 (es) | Compuestos derivados de espiroindolinas, moduladores de receptores de quimiocinas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar aterosclerosis, dolor inflamatorio, influenza, sindrome metabolico, entre otras enfermedades. | |
BRPI0820388A2 (pt) | Molécula concatenada para a modulação da atividade do sistema imunológico humano e animal, composição, kit, fármaco e uso | |
CL2008001280A1 (es) | Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano. | |
CL2009001370A1 (es) | Formas cristalinas de (r,s)-, (r)- y (s)-dopc; proceso de preparacion; composicion farmaceutica; y su uso para preparar medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |